Factors Influencing Essential Hypertension and Cardiovascular Disease Modeled and Analyzed using Stochastic Petri Nets

• Autorzy: Formanowicz D. , Rybarczyk A. , Formanowicz P.

Identyfikatory

DOI

10.3233/FI-2018-1678

• Języki publikacji: EN

Abstrakty

EN

Essential hypertension is the world’s most prevalent cardiovascular disorder, however, its etiology remains poorly understood, making it difficult to study. The evidence suggests that inflammation can lead to the development of hypertension and that oxidative stress and endothelial dysfunction are involved in the inflammatory cascade. In this work, to investigate the influence of these factors on the essential hypertension development, a stochastic Petri net model has been built and then analyzed. To obtain appropriate initial marking and kinetic rate constants for the model, a simple heuristic has been developed. The application of this variant of Petri nets allowed for taking into account some important dependencies present in the modeled system what would be impossible in the case of qualitative models. This has enabled for an in-depth analysis of the studied phenomenon and a validation of biological conclusions previously obtained on the basis of a qualitative model.

Słowa kluczowe

EN

hypertension; inflammation; stochastic Petri nets; simulation; knockout analysis

• Wydawca: IOS Press
• Czasopismo: Fundamenta Informaticae
• Rocznik: 2018
• Tom: Vol. 160, nr 1/2
• Strony: 143--165
• Opis fizyczny: Bibliogr. 42 poz., rys., tab., wykr.

Twórcy

autor

Formanowicz D.

• Department of Clinical Biochemistry and Laboratory Medicine, Poznan University of Medical Sciences, Grunwaldzka 6, 60-780 Poznań, Poland

autor

Rybarczyk A.

• Institute of Computing Science, Poznan University of Technology, Piotrowo 2, 60-965 Poznań, Poland
• Institute of Bioorganic Chemistry, Polish Academy of Sciences, Noskowskiego 12/14, 61-704 Poznań, Poland

autor

Formanowicz P.

• Institute of Computing Science, Poznan University of Technology, Piotrowo 2, 60-965 Poznań, Poland
• Institute of Bioorganic Chemistry, Polish Academy of Sciences, Noskowskiego 12/14, 61-704 Poznań, Poland

Bibliografia

• [1] Harrison DG, Guzik TJ, Lob H, Madhur M, Marvar PJ, Thabet S, Vinh A, Weyand C. Inflammation, Immunity and Hypertension. Hypertension, 2012. 57:132-140. doi:10.1161/HYPERTENSIONAHA.110.163576.
• [2] Harrison DG, Vinh A, MS M. Role of the adaptive immune system in hypertension. Current Opinion in Pharmacology, 2010;10:203-207. doi:10.1016/j.coph.2010.01.006.
• [3] Chan CT, Lieu M, Toh BH, Kyaw TS, Bobik A, Sobey CG, Drummond GR. Antibodies in the Pathogenesis of Hypertension. BioMed Research International, 2014;2014:504045. doi:10.1155/2014/504045.
• [4] Murata T. Petri nets: Properties, analysis and applications. Proceedings of the IEEE, 1989;77:541-580. doi:10.1109/5.24143.
• [5] Reisig W. Petri nets: an introduction. Springer Verlag, Heidelberg, 1985. ISBN:0-387-13723-8.
• [6] David R, Alla H. Discrete, Continuous and Hybrid Petri Nets. Springer Verlag, Berlin Heidelberg, 2010. ISBN-3642106684, 9783642106682.
• [7] Sackmann A, Heiner M, Koch I. Application of Petri net based analysis techniques to signal transduction pathways. BMC Bioinformatics, 2006;7:482. doi:10.1186/1471-2105-7-482.
• [8] Koch I, Reisig W, Schreiber F. Modeling in Systems Biology. Springer-Verlag London Limited, London, 2011. doi:10.1007/978-1-84996-474-6.
• [9] Formanowicz D, Kozak A, Głowacki T, Radom M, Formanowicz P. Hemojuvelin-hepcidin axis modeled and analyzed using Petri nets. Journal of Biomedical Informatics, 2013;46(6):1030-1043. URL https://doi.org/10.1016/j.jbi.2013.07.013.
• [10] Heiner M, Gilbert D, Donaldson R. Petri Nets for Systems and Synthetic Biology. Formal Methods for Computational Systems Biology, 2008;5016:215-264. doi:10.1007/978-3-540-68894-5-7.
• [11] Marsan M. Stochastic Petri nets: An elementary introduction. Lecture Notes in Computer Science, 1989;424:1-29. URL https://doi.org/10.1007/3-540-52494-0_23.
• [12] Heiner M, Herajy M, Liu F, Rohr C, Schwarick M. Snoopy - a unifying Petri net tool. In Proc. PETRI NETS 2012, 2012;7347:398-407. doi:10.1007/978-3-642-31131-4-22.
• [13] Titze J, Shakibaei M, Schafflhuber M, Schulze-Tanzil G, Porst M, Schwind K, Dietsch P, Hilgers K. Glycosaminoglycan polymerization may enable osmotically inactive Na+ storage in the skin. American Journal of Physiology - Heart and Circulatory Physiology, 2004;287:203-208. doi:10.1152/ajpheart.01237.2003.
• [14] Titze J, Machnik A. Sodium sensing in the interstitium and relationsip to hypertension. Current Opinion in Nephrology and Hypertension, 2010;19:385-392. doi:10.1097/MNH.0b013e32833aeb3b.
• [15] Titze J. Sodium balance is not just a renal affair. Current Opinion in Nephrology and Hypertension, 2014;23(2):101-105. doi:10.1097/01.mnh.0000441151.55320.c3.
• [16] Kobori H, Nangaku M, Navar L, Nishiyama A. The Intrarenal Renin-Angiotensin System: From Physiology to the Pathobiology of Hypertension and Kidney Disease. Pharmacological Reviews, 2007;59(3):251-287. doi:10.1124/pr.59.3.3.
• [17] Husain K, Hernandez W, Ansari R, Ferder L. Inflammation, oxidative stress and renin angiotensin system in atherosclerosis. World Journal of Biological Chemistry, 2015;6(3):209-217. doi:10.4331/wjbc.v6.i3.209.
• [18] Harrison D, Vinh A, Lob H, Madhu M. Role of the Adaptive Immune System in Hypertension. Current Opinion in Ppharmacology, 2010;10(2):203-207. doi:10.1016/j.coph.2010.01.006.
• [19] Madhur M, Harrison D. Senescent T cells and hypertension: new ideas about old cells. Hypertension, 2013;62(1):13-15. doi:10.1161/HYPERTENSIONAHA.113.01410.
• [20] Harrison D. The Immune System in Hypertension. Transactions of the American Clinical and Climatological Association, 2014;125:130-140. doi:10.1007/s12026-014-8548-6.
• [21] Kawashima S, Yokoyama M. Dysfunction of Endothelial Nitric Oxide Synthase and Atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology, 2004;24(6):998-1005. URL https://doi.org/10.1161/01.ATV.0000125114.88079.96.
• [22] Li Q, Yon JY, Cai H. Mechanisms and consequences of eNOS dysfunction in hypertension. Journal of Hypertension, 2015;33:1128-1136. doi:10.1097/HJH.0000000000000587.
• [23] Hage F. C-reactive protein and hypertension. Journal of Human Hypertension, 2014;28:410-415. doi:10.1038/jhh.2013.111.
• [24] Brandes R. Endothelial dysfunction and hypertension. Recent Andvances in Hypertension, 2014;64:924-928. URL https://doi.org/10.1161/HYPERTENSIONAHA.114.03575.
• [25] Kizhakekuttu T, Widlansky M. Natural antioxidants and hypertension: promise and challenges. Cardiovascular Therapeutics, 2010;28:20-32. doi:10.1111/j.1755-5922.2010.00137.x.
• [26] Machnik A, Neuhofer W, Jantsch J, Dahlmann A, Tammela T, Machura K, Park JK, Beck FX, Müller D, Derer W, Goss J, Ziomber A, Dietsch P, Wagner H, van Rooijen N, Kurtz A, Hilgers K, Alitalo K, Eckardt KU, Luft F, Kerjaschki D, Titze J. Macrophages regulate salt-dependent volume and blood pressure by a vascular endothelial growth factor-Cdependent buffering mechanism. Nature Medicine, 2009;15:545-552. doi:10.1038/nm.1960.
• [27] Formanowicz D, Rybarczyk A, Radom M, Formanowicz P. A role of inflammation and immunity in essential hypertension - modeled and analyzed using Petri nets. Submitted for publication, 2016.
• [28] Scheidel J, Lindauer K, Ackermann J, Koch I. Quasi-Steady-State Analysis based on Structural Modules and Timed Petri Net Predict Systems Dynamics: The Life Cycle of the Insulin Receptor. Metabolites, 2015;5:766-793. doi:10.3390/metabo5040766.
• [29] Paul G, Marchelletta R, McCole D, Barrett K. Interferon-γ alters downstream signaling originating from epidermal growth factor receptor in intestinal epithelial cells: functional consequences for ion transport. Journal of Biological Chemistry, 2012;287:2144-2155. doi:10.1074/jbc.M111.318139.
• [30] Watson RR. DHEA in Human Health and Aging. CRC Press, 2011. ISBN 9781439838839. doi:10.1201/b11019-26.
• [31] Janeway CA, Travers JP, Walport M, Shlomchik MJ. Immunobiology: The Immune System in Health and Disease. New York: Garland Science, 2001. 5th edition. ISBN 081533642X.
• [32] Palsson S, Hickling TP, Bradshaw-Pierce EL, Zager M, Jooss K, Brien PJO, Spilker ME, Palsson BO, Vicini P. The development of a fully-integrated immune response model (FIRM) simulator of the immune response through integration of multiple subset models. BMC Systems Biology, 2013;7:95. doi:10.1074/jbc.M111.318139.
• [33] Tsang JYC, Lamm WJE. Estimation of endothelin-mediated vasoconstriction in acute pulmonary thromboembolism. Pulm Circ, 2012;2:67-74. doi:10.4103/2045-8932.94836.
• [34] Gillespie DT. Exact stochastic simulation of coupled chemical reactions. Journal of Physical Chemistry, 1977;81:2340-2361. doi:10.1021/j100540a008.
• [35] MacEwan D. TNF ligands and receptors-a matter of life and death. British Journal of Pharmacology, 2002;135:855-75. doi:10.1038/sj.bjp.0704549.
• [36] Atluri P, Karakousis G, Porrett P, Kaiser L. The Surgical Review: An Integrated Basic and Clinical Science Study Guide. Lippincott Williams & Wilkins, 2006. 2nd edition. ISBN 0781756413.
• [37] Jin R, Yang G, Li G. Inflammatory mechanisms in ischemic stroke: role of inflammatory cells. Journal of Leukocyte Biology, 2010;87:779-89. doi:10.1189/jlb.1109766.
• [38] Heiner M, Lehrack S, Gilbert D, Marwan W. Extended Stochastic Petri Nets for Model-Based Design of Wetlab Experiments. Transactions on Computational Systems Biology XI, 2009;5750:138-163. doi:10.1007/978-3-642-04186-07.
• [39] Grunwald S, Speer A, Ackermann J, Koch I. Petri net modelling of gene regulation of the Duchenne muscular dystrophy. Biosystems, 2008;92:189-205. doi:10.1016/j.biosystems.2008.02.005.
• [40] Madhur M, Lob H, McCann L, Iwakura Y, Blinder Y, Guzik T, Harrison D. IL-17 promotes angiotensin II-induced hypertension and vascular dysfunction. Hypertension, 2010;55(2):500-507. doi:10.1161/HYPERTENSIONAHA.109.145094.
• [41] te Riet L, van Esch JH, Roks AJ, van den Meiracker AH, Danser AJ. Hypertension: Renin-Angiotensin-Aldosterone System Alterations. Circulation Research, 2015;116(6):960-975. doi:10.1161/CIRCRESAHA.116.303587. http://circres.ahajournals.org/content/116/6/960.full.pdf.
• [42] Sesso H, Buring J, Rifai N, Blake G, Gaziano J, Ridker P. C-reactive protein and the risk of developing hypertension. The Journal of the American Medical Association, 2003;290:2945-2951.doi:10.1001/jama.290.22.2945.

Uwagi

Opracowanie rekordu w ramach umowy 509/P-DUN/2018 ze środków MNiSW przeznaczonych na działalność upowszechniającą naukę (2018).